GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Adjusted EPS | ₹-53.21 | ₹10.53 | ₹33.37 | ₹34.38 | ₹27.50 |
What is the latest Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS ?
Year | Earnings Per Share (EPS) |
---|---|
Mar2025 | ₹-53.21 |
Mar2024 | ₹10.53 |
Mar2023 | ₹33.37 |
Mar2022 | ₹34.38 |
Mar2021 | ₹27.50 |
How is Earnings Per Share (EPS) of GLENMARK PHARMACEUTICALS Trending?
Years | Earnings Per Share (EPS) | % Change | |
---|---|---|---|
Mar2025 | ₹-53.21 | Negative | |
Mar2024 | ₹10.53 | -68.44 | |
Mar2023 | ₹33.37 | -2.94 | |
Mar2022 | ₹34.38 | 25.02 | |
Mar2021 | ₹27.50 | - |
Compare Earnings Per Share (EPS) of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹58,827.4 Cr | -0.7% | 8.4% | 23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -0.7% |
8.4% |
23.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses